Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study ...

Correspondence to Professor Heather J Zar, Department of Paediatrics and Child Health, 5th Floor, ICH Building, Red Cross War Memorial Children's Hospital, Cape Town 7700, South Africa; heather.zar{at ...

1 Department of Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne 3181, Australia 2 Department of Epidemiology and Preventive Medicine, Alfred Hospital and Monash ...

Introduction and aims This study aimed to evaluate the effect of two different non-pharmacological interventions (asthma management plan and annual asthma review) on asthma exacerbations, one year ...

2 GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands Correspondence to Loes E M Kistemaker, Department of Molecular Pharmacology, ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Introduction Cilia are critically important in the mucociliary clearance of the airways. This study explores the long-term effects of SARS-CoV-2 on cilial function and regeneration. Aim We aimed to ...

BACKGROUND Inhaled corticosteroids are the most efficacious anti-inflammatory drugs in asthma. International guidelines also advocate the early introduction of inhaled corticosteroids in ...

Background Inhaled mannitol provokes bronchoconstriction via mediators released during osmotic degranulation of inflammatory cells, and, hence represents a useful diagnostic test for asthma and model ...

Title: Evidence of Shared Decision Making in a COPD education and supported self-management group setting. Authors: Jen Tomkinson, Advanced Respiratory Physiotherapist, Specialist Services (Long Term ...

Idiopathic Pulmonary Fibrosis (IPF) is a progressive, scarring lung disease with a poor prognosis and median survival of 3 years. It is a heterogeneous disorder with varying rates of progression, ...

7 Clinical Development, Early Respiratory and Immunology, BioPharmaceuticals RandD, AstraZeneca, Barcelona, Spain 8 Clinical Development, Early Respiratory and Immunology, BioPharmaceuticals RandD, ...